- Bio-Rad Reports First-Quarter 2024 Financial Results
- Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference
- Bio-Rad Announces Life Science Group Management Changes
- Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
- Bio-Rad’s Chief Operating Officer Andrew Last to Retire
- Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer
More ▼
Key statistics
On Wednesday, Bio Rad Laboratories Inc (BIO:NYQ) closed at 291.84, 11.56% above the 52 week low of 261.59 set on Oct 30, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 288.92 |
---|---|
High | 295.59 |
Low | 288.92 |
Bid | 265.80 |
Offer | 302.00 |
Previous close | 289.45 |
Average volume | 201.01k |
---|---|
Shares outstanding | 28.52m |
Free float | 19.98m |
P/E (TTM) | -- |
Market cap | 8.21bn USD |
EPS (TTM) | -10.36 USD |
Data delayed at least 15 minutes, as of May 23 2024 00:00 BST.
More ▼